Home » Topics » HIV/AIDS, BioWorld Science

HIV/AIDS, BioWorld Science
RSS

Gilead Sciences presents novel agents for HIV infection

July 24, 2013

MBio Diagnostics receives NIH grant to continue development of POC HIV diagnostic device

July 23, 2013

Janssen and Pepscan patent novel polypeptide HIV fusion inhibitors

July 18, 2013

Boehringer Ingelheim divulges novel reverse transcriptase inhibitors

July 12, 2013

Janssen announces approval of a high-dose HIV therapeutic

July 11, 2013

Calimmune commences phase I/II trial of gene medicine for HIV

July 10, 2013

Gilead Sciences presents further clinical data on Stribild

July 9, 2013

Coadministration of long-acting GSK-744 and rilpivirine found feasible

July 8, 2013

Results from phase III trials of dolutegravir presented

July 5, 2013

In vitro and in vivo anti-HIV activity of a novel HIV-1 splicing inhibitor

July 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...